Task Shifting and Blood Pressure Control in Ghana (TASSH)
Hypertension, High Blood Pressure, Cardiovascular Diseases

About this trial
This is an interventional treatment trial for Hypertension focused on measuring Hypertension, High Blood Pressure, Cardiovascular Diseases, Health Insurance Coverage, Low income countries, Ghana, Low resource settings, Comparative Effectiveness, Global Health
Eligibility Criteria
Inclusion Criteria:
- Health facility Inclusion: Participating health facilities will be selected from areas that are geographically distant from one another with equal urban/rural mix in the Ashanti Region, which has 170 community health centers. Of these, we will recruit 32 for this study. Eligible facilities must have at least one community health nurse employed in the CHPS program; be a certified National Health Insurance Scheme (NHIS) provider; and have basic capability for blood tests.
- Patient Inclusion: To be eligible for the study, patients must fulfill the following criteria: a) are registered to receive care at the health center; b) are adults age 40 years and older; c) have BP 140-179/90-100 mm Hg and are not on treatment for hypertension; and c) can provide informed consent. Given low literacy levels, consent will be provided both verbally and in written form.
Exclusion Criteria:
-Patients will be excluded if they have: a) previous diagnosis of diabetes, coronary artery disease, transient ischemic attacks, stroke, heart failure, or angina: b) BP>180/100 mm Hg; c) positive urine dipstick for protein; d) are pregnant; and e) unable to comply with the follow-up requirements or provide informed consent. Patients with history of transient ischemic attacks (TIAs), stroke, heart failure, diabetes, angina, claudication, and BP>180/100 mm Hg will be referred to the district hospitals for further management.
Sites / Locations
- Kwame Nkrumah University of Science and Technology
Arms of the Study
Arm 1
Arm 2
Active Comparator
Sham Comparator
WHO CVD Risk Assessment package
Health Insurance only
Arm#1 (Intervention Group): Provided Ghana's National Health Insurance and the WHO CVD Risk Assessment package for 12 months.
Arm#2 (Control group): Provided Ghana's National Health Insurance for 12 months, brief behavioral counseling at baseline,and usual care.